These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 19566599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B.
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ.
    Prostaglandins Leukot Essent Fatty Acids; 2009 Nov; 81(2-3):199-204. PubMed ID: 19545988
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review.
    Weber P, Raederstorff D.
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):28-37. PubMed ID: 10812585
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of supplementation of arachidonic acid (AA) or a combination of AA plus docosahexaenoic acid on breastmilk fatty acid composition.
    Smit EN, Koopmann M, Boersma ER, Muskiet FA.
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):335-40. PubMed ID: 10913225
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A method for assessing dietary intakes of n-3 long-chain polyunsaturated fatty acids and trans fatty acids in an Irish adult population.
    Leite JC, Hearty AP, Nugent AP, Gibney MJ.
    Int J Food Sci Nutr; 2010 Sep; 61(6):583-99. PubMed ID: 20345328
    [Abstract] [Full Text] [Related]

  • 16. The utility of omega-3 fatty acids in cardiovascular disease.
    Saremi A, Arora R.
    Am J Ther; 2009 Sep; 16(5):421-36. PubMed ID: 19092647
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ, Milani RV, Mehra MR, Ventura HO.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):585-94. PubMed ID: 19660687
    [Abstract] [Full Text] [Related]

  • 20. Omega-3 fatty acids and cardiovascular disease.
    von Schacky C.
    Curr Opin Clin Nutr Metab Care; 2007 Mar 11; 10(2):129-35. PubMed ID: 17284999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.